NASDAQ:MTP Biodexa Pharmaceuticals (MTP) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.29▼$3.2252-Week Range N/AVolume164,300 shsAverage Volume57,354 shsMarket Capitalization$6.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biodexa Pharmaceuticals alerts: Email Address Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Biodexa Pharmaceuticals Stock (NASDAQ:MTP)Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.Read More Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. MTP Stock News HeadlinesAugust 12, 2024 | msn.comBiodexa Pharmaceuticals files for 4.35B ordinary shares for holdersJuly 11, 2024 | investorplace.comWhy Is Biodexa Pharmaceuticals (BDRX) Up 56% Today?September 8, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.May 21, 2024 | msn.comBiodexa rallies 80% on positive Phase 2 data for eRapaMarch 28, 2024 | benzinga.comExtend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows PotentialMarch 28, 2024 | investorplace.comWhy Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today?February 23, 2024 | msn.comBiodex stock slides 7% amid data for two drug studiesFebruary 13, 2024 | msn.comWhy Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today?September 8, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.December 19, 2023 | msn.comCrude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares PlungeDecember 19, 2023 | tmcnet.comBiodexa Announces Pricing of $5.2 Million Underwritten Public OfferingJuly 8, 2023 | benzinga.comBiodexa Pharmaceuticals PLC Announces Results Of Appeal Of Delisting DeterminationApril 25, 2023 | seekingalpha.comBDRX Biodexa Pharmaceuticals PlcApril 4, 2023 | finance.yahoo.comBiodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of EquityMarch 28, 2023 | investorplace.comWhy Is Midatech Pharma (BDRX) Stock Up 64% Today?February 9, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Private Placement Raising US $6.0 millionJanuary 23, 2023 | financialpost.comBioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plcJanuary 12, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 StudySee More Headlines Receive MTP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:MTP CUSIPN/A CIK1643918 Webwww.midatechpharma.com Phone441235888300FaxN/AEmployees18Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$800,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$5.67 per share Price / BookN/AMiscellaneous Outstanding Shares21,670,000Free Float21,595,000Market Cap$6.18 million OptionableNot Optionable Beta2.29 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesStephen Anthony StampChief Executive Officer, CFO, Secretary & DirectorDmitry ZamoryakhinChief Scientific OfficerDan PalmerVice President-TechnologySteve EllulVice President-Business DevelopmentFiona SharpGroup Financial ControllerKey CompetitorsRenovoRxNASDAQ:RNXTAcasti PharmaNASDAQ:ACSTOrgenesisNASDAQ:ORGSGeoVax LabsNASDAQ:GOVXLisata TherapeuticsNASDAQ:LSTAView All Competitors MTP Stock Analysis - Frequently Asked Questions When did Biodexa Pharmaceuticals' stock split? Biodexa Pharmaceuticals shares reverse split before market open on Monday, March 27th 2023. The 1-4 reverse split was announced on Monday, March 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What other stocks do shareholders of Biodexa Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biodexa Pharmaceuticals investors own include CRISPR Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX) and Plug Power (PLUG). This page (NASDAQ:MTP) was last updated on 9/8/2024 by MarketBeat.com Staff From Our PartnersLast Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredExposed: 3 CENT Crypto to Explode September 23rd?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.